上下连贯
发表于 2025-3-30 10:15:20
http://reply.papertrans.cn/29/2806/280553/280553_51.png
白杨
发表于 2025-3-30 15:53:33
Seprase-DPPIV Association and Prolyl Peptidase and Gelatinase Activities of the Protease Complex
愤怒事实
发表于 2025-3-30 19:32:12
Dipeptidyl Peptidase-IV Activity and/or Structure Homologues (DASH) in Transformed Neuroectodermal C
maudtin
发表于 2025-3-31 00:13:16
http://reply.papertrans.cn/29/2806/280553/280553_54.png
污点
发表于 2025-3-31 03:03:23
0065-2598 ne mechanisms and immune disorders, .- Cancer and angiogenesis, .- Diabetes and metabolism, .- Therapeutic implications. .978-1-4757-8730-6978-0-306-47920-5Series ISSN 0065-2598 Series E-ISSN 2214-8019
CBC471
发表于 2025-3-31 06:56:04
New Results on the Conformations of Potent DP IV (CD26) Inhibitors bearing the N-terminal , Structur structural class for the interaction with DP IV..Thus, the considerable enhancement of the inhibition capacity of both .-. and . compared to the moderate inhibitor ., .=2.68±0.01 10. ., can only be due to tryptophan in the second position suggesting that its side chain is favored to exhibit attract
Minatory
发表于 2025-3-31 10:16:53
http://reply.papertrans.cn/29/2806/280553/280553_57.png
NOVA
发表于 2025-3-31 17:18:41
Synergistic Action of DPIV and APN in the Regulation of T Cell FunctionPN or DPIV alone. Therefore, the simultaneous inhibition of these enzymes represents a promising strategy for the pharmacological therapy of T cell mediated diseases such as autoimmune disease, inflammation, allergy, and allograft rejection.
四指套
发表于 2025-3-31 18:05:22
CD26/DPP IV in Experimental and Clinical Organ Transplantationific inhibition abrogated acute (p<0.0001) and accelerated (p<0.01) rejection, impairing cytotoxicity and allospecific Ig-synthesis. Kidney recipients displayed a significant drop in CD26 expression on PBL for up to 18 months postoperatively (p<0.001). CD4, 8, 45, 122 and ADA expression kinetics wer
canonical
发表于 2025-3-31 22:06:54
Book 2003The sections of the book focus on various topics: ..- Structure and function of dipeptidyl aminopeptidases, .- DPP IV-like proteins, .- Immune mechanisms and immune disorders, .- Cancer and angiogenesis, .- Diabetes and metabolism, .- Therapeutic implications. .